Jean Jacques Bienaime, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 2,000 shares at $85.51 ($172K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Seasonal sale ($172k) by Director — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.51 | 1,000 | $86K | 49.7% |
| 2 | $86.71 | 1,000 | $87K | 50.3% |
| Total | $86.11 avg | 2,000 | $172K | 100% |
| Filing → |
| KROS | BUY | 2026-07-17 | $11K | — | Filing → |
| KROS | BUY | 2026-06-17 | $10K | — | Filing → |
| IMNM | BUY | 2026-06-09 | $204K | — | Filing → |